Last updated Septmber 2023 - School of Pharmacy
1.
Agbaria M, Jbara-Agbaria D, Grad E, Ben-David-Naim M, Aizik G, Golomb G. Nanoparticles of VAV1 siRNA combined with LL37 peptide for the treatment of pancreatic cancer. Journal of Controlled Release [Internet]. 2023;355:312–26. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85147544706&doi=10.1016%252fj.jconrel.2023.01.084&partnerID=40&md5=e2983fbba8078a02a6db3190f9fa3073
2.
Hirsch S, Hinden L, Naim MBD, Baraghithy S, Permyakova A, Azar S, et al. Hepatic targeting of the centrally active cannabinoid 1 receptor (CB1R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes. Journal of Controlled Release [Internet]. 2023;353:254–69. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85143528111&doi=10.1016%252fj.jconrel.2022.11.040&partnerID=40&md5=e2edaefdd17e2f721e5487deb7fc7946
3.
Biswas S, Rust LN, Wettengel JM, Yusova S, Fischer M, Carson JN, et al. Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity. Nature Communications [Internet]. 2022;13(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130895830&doi=10.1038%252fs41467-022-30593-0&partnerID=40&md5=5d7995eed7972f87ed085641d33c7282
4.
Jbara-Agbaria D, Blondzik S, Burger-Kentischer A, Agbaria M, Nordling-David MM, Giterman A, et al. Liposomal siRNA Formulations for the Treatment of Herpes Simplex Virus-1: In Vitro Characterization of Physicochemical Properties and Activity, and In Vivo Biodistribution and Toxicity Studies. Pharmaceutics [Internet]. 2022;14(3). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85127097172&doi=10.3390%252fpharmaceutics14030633&partnerID=40&md5=0d89d08cbdef64f01ff509d66acc6775
5.
Shvindelman O, Nordling-David MM, Grad E, Golomb G. Harnessing Monocytes for a Liposomal Rosiglitazone-Mediated Anti-Inflammatory Effect. Precision Nanomedicine [Internet]. 2022;5(4):930–45. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85159659208&doi=10.33218%252f001c.38312&partnerID=40&md5=d659848576cd7d431bc45d1d460755e2
6.
Aizik G, Waiskopf N, Agbaria M, Ben-David-Naim M, Nordling-David MM, Jbara-Agbaria D, et al. Targeting and imaging of monocyte-derived macrophages in rat’s injured artery following local delivery of liposomal quantum dots. Journal of Controlled Release [Internet]. 2020;318:145–57. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076559543&doi=10.1016%252fj.jconrel.2019.12.009&partnerID=40&md5=ef72c87b8c964db6191dfb3ff972eafa
7.
Aizik G, Waiskopf N, Agbaria M, Ben-David-Naim M, Levi-Kalisman Y, Shahar A, et al. Liposomes of Quantum Dots Configured for Passive and Active Delivery to Tumor Tissue. Nano Letters [Internet]. 2019;19(9):5844–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072134106&doi=10.1021%252facs.nanolett.9b01027&partnerID=40&md5=48afce524f29a42454895a0b48f09f0d
8.
Grad E, Gutman D, Golomb M, Efraim R, Oppenheim A, Richter I, et al. Monocyte Modulation by Liposomal Alendronate Improves Cardiac Healing in a Rat Model of Myocardial Infarction. Regenerative Engineering and Translational Medicine [Internet]. 2019;5(3):280–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073012050&doi=10.1007%252fs40883-019-00103-8&partnerID=40&md5=9c8fdd05443b5f68f950b593e38531b9
9.
Ben-David-Naim M, Dagan A, Grad E, Aizik G, Nordling-David MM, Clyne AM, et al. Targeted siRNA nanoparticles for mammary carcinoma therapy. Cancers [Internet]. 2019;11(4). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065305603&doi=10.3390%252fcancers11040442&partnerID=40&md5=e78ea2b3d0c526b738a6e41ee6101096
10.
Chorny M, Levy RJ, Golomb G. Cardiovascular delivery of drugs and biotherapeutics. Drug Delivery and Translational Research [Internet]. 2018;8(4):865–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049243020&doi=10.1007%252fs13346-018-0483-y&partnerID=40&md5=b0b79a202b1b159cbe54ff2ab032b1b6
11.
Aizik G, Grad E, Golomb G. Monocyte-mediated drug delivery systems for the treatment of cardiovascular diseases. Drug Delivery and Translational Research [Internet]. 2018;8(4):868–82. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049169246&doi=10.1007%252fs13346-017-0431-2&partnerID=40&md5=f43fcc1ba5bd3c3019d6ec945eba4ae7
12.
Grad E, Zolotarevsky K, Danenberg HD, Nordling-David MM, Gutman D, Golomb G. The role of monocyte subpopulations in vascular injury following partial and transient depletion. Drug Delivery and Translational Research [Internet]. 2018;8(4):945–53. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043480488&doi=10.1007%252fs13346-017-0404-5&partnerID=40&md5=ff1ca1f2a55074302dd237dba2d3824d
13.
Ben David-Naim M, Grad E, Aizik G, Nordling-David MM, Moshel O, Granot Z, et al. Polymeric nanoparticles of siRNA prepared by a double-emulsion solvent-diffusion technique: Physicochemical properties, toxicity, biodistribution and efficacy in a mammary carcinoma mice model. Biomaterials [Internet]. 2017;145:154–67. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85028427631&doi=10.1016%252fj.biomaterials.2017.08.036&partnerID=40&md5=912aa8cf30ff0530d3157f8246347388
14.
Nordling-David MM, Yaffe R, Guez D, Meirow H, Last D, Grad E, et al. Liposomal temozolomide drug delivery using convection enhanced delivery. Journal of Controlled Release [Internet]. 2017;261:138–46. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021446059&doi=10.1016%252fj.jconrel.2017.06.028&partnerID=40&md5=1a0de4135ee5b08cffe4b2ec899d57fe
15.
Aizik G, Waiskopf N, Agbaria M, Levi-Kalisman Y, Banin U, Golomb G. Delivery of Liposomal Quantum Dots via Monocytes for Imaging of Inflamed Tissue. ACS Nano [Internet]. 2017;11(3):3038–51. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016393733&doi=10.1021%252facsnano.7b00016&partnerID=40&md5=b2292ba5caedfcee0f07fe28fca20bcc
16.
Ron-Doitch S, Sawodny B, Kühbacher A, David MMN, Samanta A, Phopase J, et al. Reduced cytotoxicity and enhanced bioactivity of cationic antimicrobial peptides liposomes in cell cultures and 3D epidermis model against HSV. Journal of Controlled Release [Internet]. 2016;229:163–71. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962415123&doi=10.1016%252fj.jconrel.2016.03.025&partnerID=40&md5=9f598ff14a8e02564e0e2123a090e48e
17.
Epstein H, Afergan E, Koroukhov N, Eisenberg G, Gutman D, Golomb G. Liposomal bisphosphonates for the treatment of restenosis [Internet]. Vol. 2, Liposome Technology: Third Edition. 2016. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052168926&partnerID=40&md5=755ed7354233f9e4a27ea58069ab1b3b
18.
Lurier E, Levy R, Barbee K, Golomb G, Spiller KL. Effects of radical oxygen species and antioxidants on macrophage polarization. In: 2015 41st Annual Northeast Biomedical Engineering Conference, NEBEC 2015 [Internet]. 2015. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84941101646&doi=10.1109%252fNEBEC.2015.7117113&partnerID=40&md5=10d7037d664cf0322d44d096b0fdb452
19.
Burwitz BJ, Reed JS, Hammond KB, Ohme MA, Planer SL, Legasse AW, et al. Technical advance: Liposomal alendronate depletes monocytes and macrophages in the nonhuman primate model of human disease. Journal of Leukocyte Biology [Internet]. 2014;96(3):491–501. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907358202&doi=10.1189%252fjlb.5TA0713-373R&partnerID=40&md5=3cf8cc5314eb02de4267b997c6259617
20.
Nordling-David MM, Golomb G. Gene delivery by liposomes. Israel Journal of Chemistry [Internet]. 2013;53(9–10):737–47. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84894634150&doi=10.1002%252fijch.201300055&partnerID=40&md5=07043d9d6513b61b87d7fc7981256e6b
21.
Gutman D, Golomb G. Liposomal alendronate for the treatment of restenosis. Journal of Controlled Release [Internet]. 2012;161(2):619–27. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862688093&doi=10.1016%252fj.jconrel.2011.11.037&partnerID=40&md5=ab73885832d584ce7e813e7d35fe35a9
22.
Reufsteck C, Lifshitz-Shovali R, Zepp M, Bäuerle T, Kübler D, Golomb G, et al. Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions. Clinical and Experimental Metastasis [Internet]. 2012;29(5):441–56. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862335808&doi=10.1007%252fs10585-012-9462-8&partnerID=40&md5=9d6384bb46de92153833e8dca3fa5c77
23.
Chan JM, Rhee JW, Drum CL, Bronson RT, Golomb G, Langer R, et al. In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles. Proceedings of the National Academy of Sciences of the United States of America [Internet]. 2011;108(48):19347–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-82755187704&doi=10.1073%252fpnas.1115945108&partnerID=40&md5=d3fcc1726bab70902b314b750c396d52
24.
Gutman D, Epstein-Barash H, Tsuriel M, Golomb G. Alendronate liposomes for antitumor therapy: Activation of γδ T cells and inhibition of tumor growth. Advances in Experimental Medicine and Biology [Internet]. 2011;733:165–79. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84934442719&doi=10.1007%252f978-94-7-2555-3_16&partnerID=40&md5=d5618d32459def31ea2ac0a1d47881d0
25.
Afergan E, Najajreh Y, Gutman D, Epstein H, Elmalak O, Golomb G. 31P-NMR and differential scanning calorimetry studies for determining vesicle’s drug physical state and fraction in alendronate liposomes. Journal of Bioanalysis and Biomedicine [Internet]. 2010;2(6):125–31. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952585735&doi=10.4172%252f1948-593X.1000035&partnerID=40&md5=10a068791d6d68215f975e8c613b274d
26.
Haber E, Afergan E, Epstein H, Gutman D, Koroukhov N, Ben-David M, et al. Route of administration-dependent anti-inflammatory effect of liposomal alendronate. Journal of Controlled Release [Internet]. 2010;148(2):226–33. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-78649323529&doi=10.1016%252fj.jconrel.2010.08.030&partnerID=40&md5=9be7fbc64737ca31d38e7e8ea0f312e2
27.
Epstein-Barash H, Gutman D, Markovsky E, Mishan-Eisenberg G, Koroukhov N, Szebeni J, et al. Physicochemical parameters affecting liposomal bisphosphonates bioactivity for restenosis therapy: Internalization, cell inhibition, activation of cytokines and complement, and mechanism of cell death. Journal of Controlled Release [Internet]. 2010;146(2):182–95. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955416877&doi=10.1016%252fj.jconrel.2010.03.011&partnerID=40&md5=52c22ecc9d1bf5e66c4508c012313372
28.
Afergan E, David MB, Epstein H, Koroukhov N, Gilhar D, Rohekar K, et al. Liposomal simvastatin attenuates neointimal hyperplasia in rats. AAPS Journal [Internet]. 2010;12(2):181–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950685982&doi=10.1208%252fs12248-010-9173-5&partnerID=40&md5=1415639735e2af4725e69cdb52caba9d
29.
Elazar V, Adwan H, Bäuerle T, Rohekar K, Golomb G, Berger MR. Sustained delivery and efficacy of polymeric nanoparticles containing osteopontin and bone sialoprotein antisenses in rats with breast cancer bone metastasis. International Journal of Cancer [Internet]. 2010;126(7):1749–60. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77449113087&doi=10.1002%252fijc.24890&partnerID=40&md5=a1f3851042833be3cc93844ff42a3c27
30.
Chan JM, Zhang L, Tong R, Ghosh D, Gao W, Liao G, et al. Spatiotemporal controlled delivery of nanoparticles to injured vasculature. Proceedings of the National Academy of Sciences of the United States of America [Internet]. 2010;107(5):2213–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-76649118810&doi=10.1073%252fpnas.0914585107&partnerID=40&md5=ee5d5f0cf878744a032c314f14afee47
31.
Cohen-Sela E, Chorny M, Gutman D, Komemi S, Koroukhov N, Golomb G. Characterization of monocytes-targeted nanocarriers biodistribution in leukocytes in ex-vivo and in-vivo models. Nano Biomedicine and Engineering [Internet]. 2010;2(2):91–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-78649325465&doi=10.5101%252fnbe.v2i2.p91-99&partnerID=40&md5=53882baea70e97c03c50067166c6a687
32.
Elazar V, Adwan H, Rohekar K, Zepp M, Lifshitz-Shovali R, Berger MR, et al. Biodistribution of antisense nanoparticles in mammary carcinoma rat model. Drug Delivery [Internet]. 2010;17(6):408–18. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77954273248&doi=10.3109%252f10717541003777225&partnerID=40&md5=6ab01753b2cb33537854f28e198a2d51
33.
Breuer E, Chorghade MS, Fischer J, Golomb G. Glossary of terms related to pharmaceutics (IUPAC Recommendations 2009). Pure and Applied Chemistry [Internet]. 2009;81(5):971–99. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-67649363798&doi=10.1351%252fPAC-REC-04-10-14&partnerID=40&md5=de89df948b1d584271e8be384f15d37d
34.
Cohen-Sela E, Chorny M, Koroukhov N, Danenberg HD, Golomb G. A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles. Journal of Controlled Release [Internet]. 2009;133(2):90–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-57349143801&doi=10.1016%252fj.jconrel.2008.09.073&partnerID=40&md5=965461d94cc786db31d84447ab8cbdf6
35.
Afergan E, Epstein H, Koroukhov N, Klein M, Litchi A, Mishani E, et al. Biodistribution and imaging studies of 67Ga-labeled liposomes in rabbits with a vascular injury. Journal of Drug Delivery Science and Technology [Internet]. 2009;19(4):263–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-69249113493&doi=10.1016%2fS1773-2247%2809%2950050-0&partnerID=40&md5=22d7ad7dc1f9f16f0bcfcb5a2e83f87f
36.
Gutman D, Epstein H, Koroukhov N, Golomb G. Liposomal delivery system of adenosine for modulating inflammation. Journal of Drug Delivery Science and Technology [Internet]. 2009;19(4):257–62. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-69249084975&doi=10.1016%2fS1773-2247%2809%2950049-4&partnerID=40&md5=7bd611d69653e8bb6729e1a9eb6ba7a0
37.
Cohen-Sela E, Teitlboim S, Chorny M, Koroukhov N, Danenberc HD, Gao J, et al. Single and double emulsion manufacturing techniques of an amphiphilic drug in PLGA nanoparticles: Formulations of mithramycin and bioactivity. Journal of Pharmaceutical Sciences [Internet]. 2009;98(4):1452–62. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-67449168069&doi=10.1002%252fjps.21527&partnerID=40&md5=7e1825e4882147bc4673d17a55d80505
38.
Haber E, Danenberg HD, Koroukhov N, Ron-El R, Golomb G, Schachter M. Peritoneal macrophage depletion by liposomal bisphosphonate attenuates endometriosis in the rat model. Human Reproduction [Internet]. 2009;24(2):398–407. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-58449108637&doi=10.1093%252fhumrep%252fden375&partnerID=40&md5=2d7a2b84b68188c511f7dfdd7505285e
39.
Afergan E, Epstein H, Dahan R, Koroukhov N, Rohekar K, Danenberg HD, et al. Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes. Journal of Controlled Release [Internet]. 2008;132(2):84–90. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-56349113764&doi=10.1016%252fj.jconrel.2008.08.017&partnerID=40&md5=57702b81965a71013f275818dbe24d7d
40.
Epstein H, Gutman D, Cohen-Sela E, Haber E, Elmalak O, Koroukhov N, et al. Preparation of alendronate liposomes for enhanced stability and bioactivity: In vitro and in vivo characterization. AAPS Journal [Internet]. 2008;10(4):505–15. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-65549118918&doi=10.1208%252fs12248-008-9060-5&partnerID=40&md5=d24e5007d9d4b3e80d9535e72541162b
41.
Epstein H, Grad E, Golomb M, Koroukhov N, Edelman ER, Golomb G, et al. Innate immunity has a dual effect on vascular healing: Suppression and aggravation of neointimal formation and remodeling post-endotoxin challenge. Atherosclerosis [Internet]. 2008;199(1):41–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-45449103496&doi=10.1016%252fj.atherosclerosis.2007.10.034&partnerID=40&md5=93792d45294de985c67cafcea0a696bb
42.
Markovsky E, Koroukhov N, Golomb G. Additive-free albumin nanoparticles of alendronate for attenuating inflammation through monocyte inhibition. Nanomedicine [Internet]. 2007;2(4):545–53. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548406554&doi=10.2217%252f17435889.2.4.545&partnerID=40&md5=9d1f8b0563379ea2ed34a2fb33a4a93b
43.
Cohen-Sela E, Elazar V, Epstein-Barash H, Golomb G. Nano-Carriers of drugs and genes for the treatment of restenosis [Internet]. Nanoparticulate Drug Delivery Systems. 2007. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015888227&partnerID=40&md5=47666313a38b94f7b65b2fa34cf03f22
44.
Epstein H, Berger V, Levi I, Eisenberg G, Koroukhov N, Gao J, et al. Nanosuspensions of alendronate with gallium or gadolinium attenuate neointimal hyperplasia in rats. Journal of Controlled Release [Internet]. 2007;117(3):322–32. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846796351&doi=10.1016%252fj.jconrel.2006.10.030&partnerID=40&md5=412258e314017519688596066906cf26
45.
Cohen-Sela E, Dangoor D, Epstein H, Gati I, Danenberg HD, Golomb G, et al. Nanospheres of a bisphosphonate attenuate intimal hyperplasia. Journal of Nanoscience and Nanotechnology [Internet]. 2006;6(9–10):3226–34. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33750067376&doi=10.1166%252fjnn.2006.428&partnerID=40&md5=500c656c62b4d17a930d842ee29ff9f7
46.
Chorny M, Mishaly D, Leibowitz A, Domb AJ, Golomb G. Site-specific delivery of dexamethasone from biodegradable implants reduces formation of pericardial adhesions in rabbits. Journal of Biomedical Materials Research - Part A [Internet]. 2006;78(2):276–82. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33745938553&doi=10.1002%252fjbm.a.30755&partnerID=40&md5=b6029fb0b0d8398d560d1b7fe7bf1a41
47.
Cohen-Sela E, Rosenzweig O, Gao J, Epstein H, Gati I, Reich R, et al. Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis. Journal of Controlled Release [Internet]. 2006;113(1):23–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33744535630&doi=10.1016%252fj.jconrel.2006.03.010&partnerID=40&md5=5e473c53fd5454b794e1508443217afb
48.
Epstein H, Afergan E, Moise T, Richter Y, Rudich Y, Golomb G. Number-concentration of nanoparticles in liposomal and polymeric multiparticulate preparations: Empirical and calculation methods. Biomaterials [Internet]. 2006;27(4):651–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-26844457912&doi=10.1016%252fj.biomaterials.2005.06.006&partnerID=40&md5=14f2169cb7efe6379f1e7e6ffedea473
49.
Banai S, Chorny M, Gertz SD, Fishbein I, Gao J, Perez L, et al. Erratum: Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries (Biomaterials (2005) 26 (451-461) DOI: 10.1016/j.biomaterials.2004.02. 040). Biomaterials [Internet]. 2005;26(23):4898–901. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-20044372876&doi=10.1016%252fj.biomaterials.2005.01.032&partnerID=40&md5=b25a1375a8e896e14cec7caecaf654fa
50.
Bejjani RA, BenEzra D, Cohen H, Rieger J, Andrieu C, Jeanny JC, et al. Nanoparticles for gene delivery to retinal pigment epithelial cells. Molecular Vision [Internet]. 2005;11:124–32. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-21644468948&partnerID=40&md5=ee23bf9e47ffd773c40afcdee02377b9
51.
Banai S, Chorny M, Gertz SD, Fishbein I, Gao J, Perez L, et al. Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries. Biomaterials [Internet]. 2005;26(4):451–61. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-3242716834&doi=10.1016%252fj.biomaterials.2004.02.040&partnerID=40&md5=00a227f7fb5ae5b5a7280bdae450de42
52.
Banai S, Gertz SD, Gavish L, Chorny M, Perez LS, Lazarovichi G, et al. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries. Cardiovascular Research [Internet]. 2004;64(1):165–71. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-4444231182&doi=10.1016%252fj.cardiores.2004.06.013&partnerID=40&md5=816c96dd4981ba2a88016185df56588d
53.
Cohen-Sacks H, Elazar V, Gao J, Golomb A, Adwan H, Korchov N, et al. Delivery and expression of pDNA embedded in collagen matrices. Journal of Controlled Release [Internet]. 2004;95(2):309–20. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-1242271280&doi=10.1016%252fj.jconrel.2003.11.001&partnerID=40&md5=0fdea78f76f166cc917d9f9e196bdf39
54.
Adwan H, Bäuerle T, Najajreh Y, Elazer V, Golomb G, Berger MR. Decreased levels of osteopontin and bone sialoprotein II are correlated with reduced proliferation, colony formation, and migration of GFP-MDA-MB-231 cells. International journal of oncology [Internet]. 2004;24(5):1235–44. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-6944233447&doi=10.3892%252fijo.24.5.1235&partnerID=40&md5=48611ff9d83fa337b5b918e117c1ec07
55.
Danenberg HD, Golomb G, Groothuis A, Gao J, Epstein H, Swaminathan RV, et al. Liposomal Alendronate Inhibits Systemic Innate Immunity and Reduces In-Stent Neointimal Hyperplasia in Rabbits. Circulation [Internet]. 2003;108(22):2798–804. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0344664339&doi=10.1161%252f01.CIR.0000097002.69209.CD&partnerID=40&md5=12f3b897d2429d0b1691d0c56e79dde6
56.
Danenberg HD, Fishbein I, Epstein H, Waltenberger J, Moerman E, Mönkkönen J, et al. Systemic Depletion of Macrophages by Liposomal Bisphosphonates Reduces Neointimal Formation Following Balloon-Injury in the Rat Carotid Artery. Journal of Cardiovascular Pharmacology [Internet]. 2003;42(5):671–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-10744222354&doi=10.1097%252f00005344-200311000-00014&partnerID=40&md5=da21357b29c22865e13e6466ef205298
57.
Gazit A, Yee K, Uecker A, Böhmer FD, Sjöblom T, Östman A, et al. Tricyclic quinoxalines as potent kinase inhibitors of PDGFR kinase, Flt3 and Kit. Bioorganic and Medicinal Chemistry [Internet]. 2003;11(9):2007–18. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037401818&doi=10.1016%2fS0968-0896%2803%2900048-8&partnerID=40&md5=92200905d3fd51b424683d0d821f7eee
58.
Pipp F, Heil M, Issbrücker K, Ziegelhoeffer T, Martin S, Den Heuvel JV, et al. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: Evidence for a monocyte-mediated mechanism. Circulation Research [Internet]. 2003;92(4):378–85. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037423858&doi=10.1161%252f01.RES.0000057997.77714.72&partnerID=40&md5=3cd71f58e11c0b73d9ee3a42a74cb251
59.
Cohen-Sacks H, Najajreh Y, Tchaikovski V, Gao G, Elazer V, Dahan R, et al. Novel PDGFβR antisense encapsulated in polymeric nanospheres for the treatment of restenosis. Gene Therapy [Internet]. 2002;9(23):1607–16. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-18744410917&doi=10.1038%252fsj.gt.3301830&partnerID=40&md5=62b0d9ff1ac28ca7f9893ecbf76c0ca4
60.
Karck M, Meliss R, Hestermann M, Mengel M, Pethig K, Levitzki A, et al. Inhibition of aortic allograft vasculopathy by local delivery of platelet-derived growth factor receptor tyrosine-kinase blocker AG-1295. Transplantation [Internet]. 2002;74(9):1335–41. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037112895&doi=10.1097%252f00007890-200211150-00023&partnerID=40&md5=2b2cb521f29829b3c8cc383756684694
61.
Chorny M, Fishbein I, Danenberg HD, Golomb G. Study of the drug release mechanism from tyrphostin AG-1295-loaded nanospheres by in situ and external sink methods. Journal of Controlled Release [Internet]. 2002;83(3):401–14. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037202149&doi=10.1016%2fS0168-3659%2802%2900210-9&partnerID=40&md5=e5a72a22629980f011d8f90aca306a14
62.
Chorny M, Fishbein I, Danenberg HD, Golomb G. Lipophilic drug loaded nanospheres prepared by nanoprecipitation: Effect of formulation variables on size, drug recovery and release kinetics. Journal of Controlled Release [Internet]. 2002;83(3):389–400. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037202148&doi=10.1016%2fS0168-3659%2802%2900211-0&partnerID=40&md5=09c2fcb15c2691daaf4069529ea6e84c
63.
Danenberg HD, Fishbein I, Gao J, Mönkkönen J, Reich R, Gati I, et al. Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits. Circulation [Internet]. 2002;106(5):599–605. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037199425&doi=10.1161%252f01.CIR.0000023532.98469.48&partnerID=40&md5=00eda74a813eb2a913af1adb89b6cd4c
64.
Margolin L, Fishbein I, Banai S, Golomb G, Reich R, Perez LS, et al. Metalloproteinase inhibitor attenuates neointima formation and constrictive remodeling after angioplasty in rats: Augmentative effect of αvβ3 receptor blockade. Atherosclerosis [Internet]. 2002;163(2):269–77. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036275380&doi=10.1016%2fS0021-9150%2802%2900035-7&partnerID=40&md5=7f71d59074ca554ca7dcf5fe254afcf8
65.
Stepensky D, Golomb G, Hoffman A. Pharmacokinetic and pharmacodynamic evaluation of intermittent versus continuous alendronate administration in rats. Journal of Pharmaceutical Sciences [Internet]. 2002;91(2):508–16. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036169824&doi=10.1002%252fjps.10032&partnerID=40&md5=8c2c938058098fee10e040768fae6cdb
66.
Fishbein I, Brauner R, Chorny M, Gao J, Chen X, Laks H, et al. Local delivery of mithramycin restores vascular reactivity and inhibits neointimal formation in injured arteries and vascular grafts. Journal of Controlled Release [Internet]. 2001;77(3):167–81. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035856767&doi=10.1016%2fS0168-3659%2801%2900472-2&partnerID=40&md5=b97c438a4ba14c1cc3ae1f3db85da174
67.
Hoffman A, Stepensky D, Ezra A, Van Gelder JM, Golomb G. Mode of administration-dependent pharmacokinetics of bisphosphonates and bioavailability determination. International Journal of Pharmaceutics [Internet]. 2001;220(1–2):1–11. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035806258&doi=10.1016%2fS0378-5173%2801%2900654-8&partnerID=40&md5=c99ee5f7c3bed614871b36bf2a536020
68.
Fishbein I, Chorny M, Banai S, Levitzki A, Danenberg HD, Gao J, et al. Formulation and delivery mode affect disposition and activity of tyrphostin-loaded nanoparticles in the rat carotid model. Arteriosclerosis, Thrombosis, and Vascular Biology [Internet]. 2001;21(9):1434–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035572882&doi=10.1161%252fhq0901.095567&partnerID=40&md5=230a145ba9ef989f76234a356c29594e
69.
Chen R, Schlossman A, Breuer E, Hagele G, Tillmann C, Van Gelder JM, et al. Long-chain functional bisphosphonates: synthesis, anticalcification, and antiresorption activity. Heteroatom Chemistry [Internet]. 2000;11(7):470–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034504075&doi=10.1002%2f1098-1071%282000%2911%3a7%3c470%3a%3aAID-HC5%3e3.0.CO%3b2-P&partnerID=40&md5=785ab21d438ebab4f3899c6b0382c3e1
70.
Ezra A, Hoffman A, Breuer E, Alferiev IS, Mönkkönen J, El Hanany-Rozen N, et al. A peptide prodrug approach for improving bisphosphonate oral absorption. Journal of Medicinal Chemistry [Internet]. 2000;43(20):3641–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034609777&doi=10.1021%252fjm980645y&partnerID=40&md5=45a067bdda39b271d5fce47ec36de192
71.
Ezra A, Golomb G. Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption. Advanced Drug Delivery Reviews [Internet]. 2000;42(3):175–95. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034739243&doi=10.1016%2fS0169-409X%2800%2900061-2&partnerID=40&md5=ed8a4913e1397bd74342e56ef2dff0c2
72.
Fishbein I, Chorny M, Rabinovich L, Banai S, Gati I, Golomb G. Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis. Journal of Controlled Release [Internet]. 2000;65(1–2):221–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033997473&doi=10.1016%2fS0168-3659%2899%2900244-8&partnerID=40&md5=c4b725e89f19679cc61e32901684dae1
73.
Fishbein I, Waltenberger J, Banai S, Rabinovich L, Chorny M, Levitzki A, et al. Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neointimal formation in rats. Arteriosclerosis, Thrombosis, and Vascular Biology [Internet]. 2000;20(3):667–76. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034016296&doi=10.1161%252f01.ATV.20.3.667&partnerID=40&md5=85d694ae4d6449c19b6c98693e89b06f
74.
Chorny M, Fishbein I, Golomb G. Drug delivery systems for the treatment of restenosis. Critical Reviews in Therapeutic Drug Carrier Systems [Internet]. 2000;17(3):249–84. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033918482&doi=10.1615%252fcritrevtherdrugcarriersyst.v17.i3.20&partnerID=40&md5=4d670087dcc91dff408f1ed15be01b81
75.
Fishbein I, Chorny M, Golomb G. Treatment of restenosis by controlled-release delivery systems of tyrphostins. Drug Development Research [Internet]. 2000;50(3–4):487–96. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033809587&doi=10.1002%2f1098-2299%28200007%2f08%2950%3a3%2f4%3c487%3a%3aaid-ddr32%3e3.0.co%3b2-%2523&partnerID=40&md5=5de59a905ec748e055bb4276b5181185
76.
Yaffe A, Golomb G, Breuer E, Binderman I. The effect of topical delivery of novel bisacylphosphonates in reducing alveolar bone loss in the rat model. Journal of Periodontology [Internet]. 2000;71(10):1607–12. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033736370&doi=10.1902%252fjop.2000.71.10.1607&partnerID=40&md5=70e8a75f7a011c901cef000b447cc961
77.
Cohen H, Levy RJ, Gao J, Fishbein I, Kousaev V, Sosnowski S, et al. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Therapy [Internet]. 2000;7(22):1896–905. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033676359&doi=10.1038%252fsj.gt.3301318&partnerID=40&md5=f612133f968ca2c416931832ea2f9925
78.
Grossmann G, Grossmann A, Ohms G, Breuer E, Chen R, Golomb G, et al. Solid-state NMR of bisphosphonates adsorbed on hydroxy apatite. Magnetic Resonance in Chemistry [Internet]. 2000;38(1):11–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033622402&doi=10.1002%2f%28SICI%291097-458X%28200001%2938%3a1%3c11%3a%3aAID-MRC597%3e3.0.CO%3b2-V&partnerID=40&md5=240187392be12a1ca3ee5db192008cd8
79.
Fishbein I, Chorny M, Rabinovich L, Banai S, Gertz S, Levitzki A, et al. Formulation factors and in vivo characterization of nanoparticles in restenosis. Proceedings of the Controlled Release Society [Internet]. 1999;(26):54–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032738368&partnerID=40&md5=c00dca662955872ba951215967b9d5e8
80.
Cohen H, Alferiev IS, Mönkkönen J, Seibel MJ, Pinto T, Ezra A, et al. Synthesis and preclinical pharmacology of 2-(2-aminopyrimidinio) ethylidene-1,1-bisphosphonic acid betaine (ISA-13-1)-a novel bisphosphonate. Pharmaceutical Research [Internet]. 1999;16(9):1399–406. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032834106&doi=10.1023%252fA%253a1018951025493&partnerID=40&md5=bdbbb6be07f63800a7c4e148efd4f4ef
81.
Patlas N, Golomb G, Yaffe P, Pinto T, Breuer E, Ornoy A. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology [Internet]. 1999;60(2):68–73. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032766937&doi=10.1002%2f%28SICI%291096-9926%28199908%2960%3a2%3c68%3a%3aAID-TERA10%3e3.0.CO%3b2-H&partnerID=40&md5=389aba9b031ccd7ff1230ad0fb96210f
82.
Yaffe A, Binderman I, Breuer E, Pinto T, Golomb G. Disposition of alendronate following local delivery in a rat jaw. Journal of Periodontology [Internet]. 1999;70(8):893–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032773505&doi=10.1902%252fjop.1999.70.8.893&partnerID=40&md5=02c3b571bf28dca157618c397c800410
83.
Teomim D, Fishbien I, Golomb G, Orloff L, Mayberg M, Domb AJ. Perivascular delivery of heparin for the reduction of smooth muscle cell proliferation after endothelial injury. Journal of Controlled Release [Internet]. 1999;60(1):129–42. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033019739&doi=10.1016%2fS0168-3659%2899%2900071-1&partnerID=40&md5=fbfb7e0049c89afb6da1aa6f1960f8ab
84.
Danenberg HD, Monkkonen J, Fishbein I, Gati I, Chorny M, Banai S, et al. Controlled release of drugs from multiparticulate delivery systems in animal models of restenosis. Proceedings of the Controlled Release Society [Internet]. 1999;(26):52–3. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032759996&partnerID=40&md5=9a8a0fcf4f078e3de6e788b182db9d54
85.
Cohen H, Golomb G, Levy RJ. Gene delivery by polymer-encapsulated DNA. Proceedings of the Controlled Release Society [Internet]. 1999;(26):1136–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032755819&partnerID=40&md5=51cd0ead50da422cf700d8e29cbb04df
86.
Cohen H, Chen W, Golomb G, Levy RJ. DNA nanoparticle for gene transfer. Proceedings of the Controlled Release Society [Internet]. 1998;(25):374–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031867681&partnerID=40&md5=48b467c4aaa71c0d4aeee735c1bd72d1
87.
Cohen H, Solomon V, Alferiev IS, Breuer E, Ornoy A, Patlas N, et al. Bisphosphonates and tetracycline: Experimental models for their evaluation in calcium-related disorders. Pharmaceutical Research [Internet]. 1998;15(4):606–13. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031925310&doi=10.1023%252fA%253a1011990129437&partnerID=40&md5=bf0fcda286f28e7ecdce17386a59707b
88.
Klein BY, Ben-Bassat H, Breuer E, Solomon V, Golomb G. Structurally different bisphosphonates exert opposing effects on alkaline phosphatase and mineralization in marrow osteoprogenitors. Journal of Cellular Biochemistry [Internet]. 1998;68(2):186–94. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031974325&doi=10.1002%2f%28SICI%291097-4644%2819980201%2968%3a2%3c186%3a%3aAID-JCB5%3e3.0.CO%3b2-R&partnerID=40&md5=5fde4936bc64bd3ab3bc6ba9910e0e5d
89.
Chorny M, Fishbein I, Banai S, Levitzki A, Gertz SD, Rabinovich L, et al. In vitro and in vivo characteristics of tyrosine kinase inhibitor-containing PLA nanoparticles. Proceedings of the Controlled Release Society [Internet]. 1998;(25):667–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031867224&partnerID=40&md5=47afeecaae48cd4268d959e471d83d59
90.
Ezra A, Hoffman A, Breuer E, Weiss G, Golomb G. Proteins: Carrier-mediated absorption of bisphosphonate prodrugs. Proceedings of the Controlled Release Society [Internet]. 1998;(25):473–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031815555&partnerID=40&md5=1b03aa376ca81c111a3c5350ca052cd1
91.
Mathew M, Fowler BO, Breuer E, Golomb G, Alferiev IS, Eidelman N. Synthesis, Characterization, and Crystal Structure of Dicalcium Glutarylbis(phosphonate) Dihydrate: A Covalently Pillared Layer Structure with the Potential for Epitaxial Growth on Hydroxyapatite. Inorganic Chemistry [Internet]. 1998;37(25):6485–94. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0000574294&doi=10.1021%252fic980374h&partnerID=40&md5=160985812547c731e88b813fbf705ff7
92.
Golomb G, Fishbein I. Tyrphostins, inhibitors of protein tyrosine kinase, in restenosis. Advanced Drug Delivery Reviews [Internet]. 1997;24(1):53–62. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031568943&doi=10.1016%2fS0169-409X%2896%2900482-6&partnerID=40&md5=a797b29cd56b2385c6e43edf9f83bba2
93.
Orloff LA, Domb AJ, Teomim D, Fishbein I, Golomb G. Biodegradable implant strategies for inhibition of restenosis. Advanced Drug Delivery Reviews [Internet]. 1997;24(1):3–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031568915&doi=10.1016%2fS0169-409X%2896%2900478-4&partnerID=40&md5=4af833a746e7d00c34986eff84b21962
94.
Mishaly D, Fishbein I, Moscovitz D, Golomb G. Site-specific delivery of colchicine in rat carotid artery model of restenosis. Journal of Controlled Release [Internet]. 1997;45(1):65–73. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031015567&doi=10.1016%2fS0168-3659%2896%2901546-5&partnerID=40&md5=4092331737e7d5d8c076b81a26c61172
95.
Patlas N, Yaffe P, Kimyagarov A, Golomb G, Ornoy A. Effects of continuous or cyclic administration of pamidronate on the skeleton in intact and oophorectomized young rats; Cells Tissues Organs [Internet]. 1997;159(1):42–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85025559597&doi=10.1159%252f000147963&partnerID=40&md5=93e8d809a61494a2e785262694021867
96.
Van Gelder JM, Breuer E, Schlossman A, Ornoy A, Mönkkönen J, Similä J, et al. In vitro and in vivo effects of tetrakisphosphonates on bone resorption, tumor osteolysis, ectopic calcification, and macrophages. Journal of Pharmaceutical Sciences [Internet]. 1997;86(3):283–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-15444353872&doi=10.1021%252fjs960429h&partnerID=40&md5=7792aa9fde31265f2711b9e96d44c102
97.
Ezra A, Hoffman A, Breuer E, Weiss G, Lipka E, Amidon GL, et al. Peptidyl prodrugs for improved oral absorption. Proceedings of the Controlled Release Society [Internet]. 1997;(24):243–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030875521&partnerID=40&md5=cc95a302ef2bd7e833d61399cb7057d8
98.
Brauner R, Laks H, Drinkwater D.C. Jr, Chaudhuri G, Shvarts O, Drake T, et al. Controlled periadventitial administration of verapamil inhibits neointimal smooth muscle cell proliferation and ameliorates vasomotor abnormalities in experimental vein bypass grafts. Journal of Thoracic and Cardiovascular Surgery [Internet]. 1997;114(1):53–63. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030747898&doi=10.1016%2fS0022-5223%2897%2970117-X&partnerID=40&md5=6abd46d56a5eb7a4436db74075ece151
99.
Patashnik S, Rabinovich L, Golomb G. Preparation and evaluation of chitosan microspheres containing bisphosphonates. Journal of Drug Targeting [Internet]. 1997;4(6):371–80. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030747547&doi=10.3109%252f10611869709017894&partnerID=40&md5=256de457f30cf7e313e172367f402428
100.
Golomb G, Fishbein I, Moscovitz D, Gertz SD, Levitzki A, Pearle A, et al. Inhibitors of protein tyrosine kinase for site specific therapy of restenosis. Proceedings of the Controlled Release Society [Internet]. 1997;(24):187–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030745529&partnerID=40&md5=d94c5509777c6f3fc5c650836ffaddbf
101.
Fishbein I, Banai S, Levitzki A, Moscovitz D, Gertz SD, Gazit A, et al. Perivascular and intraluminal delivery systems of a tyrphostin for the treatment of restenosis. Proceedings of the Controlled Release Society [Internet]. 1996;(23):17–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029814279&partnerID=40&md5=d1dc7090d070b5faac7e0b8f13bb8abf
102.
Golomb G, Fishbein I, Banai S, Mishaly D, Moscovitz D, Gertz SD, et al. Controlled delivery of a tyrphostin inhibits intimal hyperplasia in a rat carotid artery injury model. Atherosclerosis [Internet]. 1996;125(2):171–82. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030572772&doi=10.1016%2f0021-9150%2896%2905868-6&partnerID=40&md5=72b6e9f856ebfa4e59b56e3d9aed679e
103.
Skrtic D, Eidelman N, Golomb G, Breuer E, Eanes ED. In vitro inhibition of membrane-mediated calcification by novel phosphonates. Calcified Tissue International [Internet]. 1996;58(5):347–54. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029939414&doi=10.1007%252fs002239900057&partnerID=40&md5=7dcf9b664dc46bb7c9b4f5b5511a45ba
104.
Schoth RM, Lork E, Seifert FU, Röschenthaler GV, Cohen H, Golomb G, et al. Routes to F3-Etidronic Acid (1-Hydroxy-2,2,2-Trifluoroethylidene-Bisphosphonic Acid), Molecular Structure of the Tris(trimethylsilyl)ester, Antimineralization, and Antiresorption Effects of the Disodium Salt. Naturwissenschaften [Internet]. 1996;83(12):571–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088621159&doi=10.1007%252fbf01141983&partnerID=40&md5=b0bb791c4b94bb03aed05db93ec21105
105.
Golomb G, Van Gelder JM, Alferiev IS, Ornoy A, Hoffman A, Schlossman A, et al. Novel bisphosphonates for calcium-related disorders. Phosphorus, Sulfur and Silicon and Related Elements [Internet]. 1996;109(1–4):221–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0043098488&doi=10.1080%252f10426509608046238&partnerID=40&md5=6f4f130c2801edf56b1d7a569f8a85da
106.
Muller DWM, Gordon D, Topol EJ, Levy RJ, Golomb G. Sustained-release local hirulog therapy decreases early thrombosis but not neointimal thickening after arterial stenting. American Heart Journal [Internet]. 1996;131(2):211–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030065126&doi=10.1016%2fS0002-8703%2896%2990343-9&partnerID=40&md5=6cf4cf56ab451ee913eda3be4754e735
107.
Golomb G. Contemporary approaches for calcitonin therapy. Proceedings of the Controlled Release Society [Internet]. 1996;(23):176–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029810483&partnerID=40&md5=036d9cf18e52126f259c958f1949de27
108.
Ezra A, Breuer E, Amidon G, Hoffman A, Ornoy A, Patlas N, et al. Peptidyl prodrug of bisphosphonates for improved oral absorption. Proceedings of the Controlled Release Society [Internet]. 1996;(23):83–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029790564&partnerID=40&md5=0188da4715da696c506c80abcae44150
109.
Huffman A, Shaked I, Avramoff A, Golomb G. Pharmacokinetics and pharmacodynamics of trans-endometrial administered peptides and macromolecules. Advanced Drug Delivery Reviews [Internet]. 1995;17(2):191–203. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029394918&doi=10.1016%2f0169-409X%2895%2900087-N&partnerID=40&md5=0d5699446bbfd23e39a85d25fa2f1065
110.
Golomb G, Shaked I, Hoffman A. Intrauterine administration of peptide drugs for systemic effect. Advanced Drug Delivery Reviews [Internet]. 1995;17(2):179–90. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029394877&doi=10.1016%2f0169-409X%2895%2900086-M&partnerID=40&md5=0c7c59c68996f39e7bbd94e5dbd661a0
111.
Golomb G. Preface. Advanced Drug Delivery Reviews [Internet]. 1995;17(2):149–50. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028871646&doi=10.1016%2f0169-409X%2895%2990010-S&partnerID=40&md5=f46dfcd32dcf622501f99d3ccd85d117
112.
Van Gelder JM, Breuer E, Ornoy A, Schlossman A, Patlas N, Golomb G. Anticalcification and antiresorption effects of bisacylphosphonates. Bone [Internet]. 1995;16(5):511–20. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029162805&doi=10.1016%2f8756-3282%2895%2900081-N&partnerID=40&md5=c0a31af7a13947e846e9f94d01cefc7e
113.
Golomb G, Fishbein I, Banai S, Moscovitz D, Mishaly D, Gertz SD, et al. Inhibition of restenosis in a rat model by perivascular delivery of a tyrphostin compound. Proceedings of the Controlled Release Society [Internet]. 1995;(22):151–2. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029155810&partnerID=40&md5=001dcd41101a92e748e98089dca5e081
114.
Hoffman A, Shaked I, Nyska A, Avramoff A, Golomb G. Trans-endometrial route of drug administration: In-vitro and in-vivo evaluation. Proceedings of the Controlled Release Society [Internet]. 1995;(22):568–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029091041&partnerID=40&md5=657dad9f4905c3f3ffdba75e5ee600a2
115.
Hoffman A, Nyska A, Avramoff A, Golomb G. Continuous versus pulsatile administration of erythropoietin (EPO) via the uterus in anemic rats. International Journal of Pharmaceutics [Internet]. 1994;111(2):197–202. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027933349&doi=10.1016%2f0378-5173%2894%2900144-8&partnerID=40&md5=2aba816c891fc3662416e84cb9b294f0
116.
Villa AE, Guzman LA, Chen W, Golomb G, Levy RJ, Topol EJ. Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. Journal of Clinical Investigation [Internet]. 1994;93(3):1243–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028223999&doi=10.1172%252fJCI117078&partnerID=40&md5=b87ccfc104412cd4cd39c3c3961add63
117.
Muller DWM, Golomb G, Gordon D, Levy RJ. Site-specific dexamethasone delivery for the prevention of neointimal thickening after vascular stent implantation. Coronary Artery Disease [Internet]. 1994;5(5):435–42. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028223812&doi=10.1097%252f00019501-199405000-00010&partnerID=40&md5=331621697a3092863317c9bd051a9af5
118.
Golomb G, Niska A, Avramoff A, Shaked I, Hoffman A. Intrauterine controlled delivery of peptides for systemic effect. Proceedings of the Controlled Release Society [Internet]. 1994;(21):38–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028091535&partnerID=40&md5=a7bfdf0d1a60a7e5b10ad5deef2a4eb5
119.
Bialer M, Hadad S, Golomb G, Barel S, Samara E, Salach OA, et al. Pharmacokinetic analysis of two new sustained‐release products of diltiazem designed for twice‐and once‐daily treatment. Biopharmaceutics & Drug Disposition [Internet]. 1994;15(1):45–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028053169&doi=10.1002%252fbdd.2510150104&partnerID=40&md5=9539d7c01955580b55054583f239bc5c
120.
Breuer E, Golomb G, Hoffman A, Schlossman A, Van Gelder JM, Saadeh H, et al. In Vitro and In Vivo Inhibition of Hydroxyapatite Formation and Dissolution by Bisacylphosphonates and Bishydroxyiminophosphonates. Phosphorus, Sulfur, and Silicon and the Related Elements [Internet]. 1993;76(1–4):167–70. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84950071810&doi=10.1080%252f10426509308032385&partnerID=40&md5=e717dd6dabd9cccf2f56a6ea98714f78
121.
Golomb G, Barashi A, Wagner D, Nachmias O. In-vitro and in-vivo models for the study of the relationship between hydrophilicity and calcification of polymeric and collageneous biornaterials. Clinical Materials [Internet]. 1993;13(1–4):61–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027272430&doi=10.1016%2f0267-6605%2893%2990092-L&partnerID=40&md5=e045117c9b9ba59bd0b763130571e480
122.
Golomb G, Avramoff A, Hoffman A. A New Route of Drug Administration: Intrauterine Delivery of Insulin and Calcitonin. Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists [Internet]. 1993;10(6):828–33. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027155556&doi=10.1023%252fA%253a1018948924992&partnerID=40&md5=d721de2e8b0fb607e15228ab34860934
123.
Levy RJ, Golomb G, Labhasetwar V. New frontiers in cardiovascular polymeric controlled release. In: Polymeric Materials Science and Engineering, Proceedings of the ACS Division of Polymeric Materials Science and Engineering [Internet]. 1992. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026993034&partnerID=40&md5=a6acbfe27f1656b31bbcb9d84ef993e8
124.
Schoen FJ, Golomb G, Levy RJ. Calcification of bioprosthetic heart valves: a perspective on models. The Journal of heart valve disease [Internet]. 1992;1(1):110–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026911171&partnerID=40&md5=b275c481db924e8baa5c7d7409346106
125.
Golomb G. Calcification of polyurethane-based biomaterials implanted subcutaneously in rats: role of porosity and fluid absorption in the mechanism of mineralization. Journal of Materials Science: Materials in Medicine [Internet]. 1992;3(4):272–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0008505120&doi=10.1007%252fBF00705292&partnerID=40&md5=b6edb5c040fef7721d028e598a0b4367
126.
Golomb G, Schlossman A, Eitan Y, Saadeh H, Van Gelder JM, Breuer E. In vitro and in vivo anticalcification effects of novel bishydroxyiminophosphonates. Journal of Pharmaceutical Sciences [Internet]. 1992;81(10):1004–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027080882&doi=10.1002%252fjps.2600811009&partnerID=40&md5=4fbb250683850ee1e7a4cd5192a56cd0
127.
Golomb G, Eitan Y, Hoffman A. Measurement of Serum [3H]Tetracycline Kinetics and Indices of Kidney Function Facilitate Study of the Activity and Toxic Effects of Bisphosphonates in Bone Resorption. Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists [Internet]. 1992;9(8):1018–23. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026611382&doi=10.1023%252fA%253a1015898226519&partnerID=40&md5=31a50c4f0b2ce481cf2c15782072d103
128.
Golomb G, Lewinstein I, Ezra V, Schoen FJ. Mechanical properties and histology of charge modified bioprosthetic tissue resistant to calcification. Biomaterials [Internet]. 1992;13(6):353–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026573356&doi=10.1016%2f0142-9612%2892%2990039-Q&partnerID=40&md5=6ba9e40e3342d32c280b59f2c775e033
129.
Golomb G, Ezra V. Covalent binding of protamine by glutaraldehyde to bioprosthetic tissue: Characterization and anticalcification effect. Biomaterials, Artificial Cells and Immobilization Biotechnology [Internet]. 1992;20(1):31–41. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026554920&doi=10.3109%252f10731199209117856&partnerID=40&md5=305348ead1ba66ede1ccac058f7e6dd5
130.
Golomb G, Schlossman A, Saadeh H, Levi M, Van Gelder JM, Breuer E. Bisacylphosphonates Inhibit Hydroxyapatite Formation and Dissolution in Vitro and Dystrophic Calcification in Vivo. Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists [Internet]. 1992;9(1):143–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026542421&doi=10.1023%252fA%253a1018956516640&partnerID=40&md5=864c0e8fdc45a43cd71b91cd1678d232
131.
Golomb G, Wagner D. Characterization and anticalcification effects of implantable polyurethane matrices containing amorphous dispersion of bisphosphonic acid. Clinical Materials [Internet]. 1991;8(1–2):33–42. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026348758&doi=10.1016%2f0267-6605%2891%2990007-3&partnerID=40&md5=f263737016597986975e00a30245beeb
132.
Golomb G, Shpigelman A. Prevention of bacterial colonization on polyurethane in vitro by incorporated antibacterial agent. Journal of Biomedical Materials Research [Internet]. 1991;25(8):937–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026205070&doi=10.1002%252fjbm.820250803&partnerID=40&md5=abffe5cb2a67d12b7885044d39e4bce1
133.
Golomb G, Ezra V. Prevention of bioprosthetic heart valve tissue calcification by charge modification: Effects of protamine binding by formaldehyde3. Journal of Biomedical Materials Research [Internet]. 1991;25(1):85–98. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026083870&doi=10.1002%252fjbm.820250107&partnerID=40&md5=fb537e6467738b6c0d477d2304e6c215
134.
Golomb G, Wagner D. Development of a new in vitro model for studying implantable polyurethane calcification. Biomaterials [Internet]. 1991;12(4):397–405. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025803939&doi=10.1016%2f0142-9612%2891%2990008-X&partnerID=40&md5=5e41b347f6c1e66b89f23cbc24759970
135.
Golomb G, Fisher P, Rahamim E. The relationship between drug release rate, particle size and swelling of silicone matrices. Journal of Controlled Release [Internet]. 1990;12(2):121–32. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025269842&doi=10.1016%2f0168-3659%2890%2990088-B&partnerID=40&md5=3f9dde625bc74afa4b6348e88f963160
136.
Levy RJ, Johnston TP, Sintov A, Golomb G. Controlled release implants for cardiovascular disease. Journal of Controlled Release [Internet]. 1990;11(1–3):245–54. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025159222&doi=10.1016%2f0168-3659%2890%2990137-I&partnerID=40&md5=00a10bbed85f5331aa42c59937eeab0f
137.
Johnston TP, Bove EL, Bolling SF, Schoen FJ, Boyd JA, Golomb G, et al. Local controlled release of 1-hydroxyethylidene diphosphonate using silicone-rubber matrices. Effects of sterilization on in vitro release and in vivo efficacy. ASAIO Transactions [Internet]. 1988;34(3):835–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023816714&partnerID=40&md5=6c4ab16516c9962640a450a8436cad41
138.
Golomb G, Schoen FJ, Smith MS, Linden J, Dixon M, Levy RJ. The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses. American Journal of Pathology [Internet]. 1987;127(1):122–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023184262&partnerID=40&md5=08f343ade0631013771067b661bd18ab
139.
Golomb G. Controlled Release of Diphosphonates from Synthetic Polymers to Inhibit Calcification. Journal of Biomaterials Applications [Internet]. 1987;2(2):266–89. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023434534&doi=10.1177%252f088532828700200205&partnerID=40&md5=336f2aeee95697d82e15499a109b6f09
140.
Golomb G, Dixon M, Smith MS, Schoen FJ, Levy RJ. Controlled‐release drug delivery of diphosphonates to inhibit bioprosthetic heart valve calcification: Release rate modulation with silicone matrices via drug solubility and membrane coating. Journal of Pharmaceutical Sciences [Internet]. 1987;76(4):271–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023227630&doi=10.1002%252fjps.2600760402&partnerID=40&md5=75322368c46ab88fcb2e82ba700c3014
141.
Golomb G, Dixon M, Smith MS, Schoen FJ, Levy RJ. Inhibition of bioprosthetic heart valve calcification by sustained local delivery of Ca and Na diphosphonate via controlled release matrices. ASAIO transactions / American Society for Artificial Internal Organs [Internet]. 1986;32(1):587–90. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022753544&partnerID=40&md5=2d1492133b369c70784d6df87b511ea7
142.
Golomb G, Langer R, Schoen FJ, Smith MS, Choi YM, Levy RJ. Controlled release of diphosphonate to inhibit bioprosthetic heart valve calcification: Dose-response and mechanistic studies. Journal of Controlled Release [Internet]. 1986;4(3):181–94. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023035506&doi=10.1016%2f0168-3659%2886%2990002-7&partnerID=40&md5=b941b93ff1a19086b9d497cb2c659eec
143.
Stabholz A, Sela MN, Friedman M, Golomb G, Soskolne A. Clinical and microbiological effects of sustained release chlorhexidine in periodontal pockets. Journal of Clinical Periodontology [Internet]. 1986;13(8):783–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023013474&doi=10.1111%252fj.1600-051X.1986.tb00882.x&partnerID=40&md5=51e44b21f665f86f48bdbd2517e4e9f9
144.
Levy RJ, Shoen FJ, Golomb G. Bioprosthetic heart valve calcification: Clinical features, pathobiology, and prospects for prevention. Critical Reviews in Biocompatibility [Internet]. 1986;2(2):147–87. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022966729&partnerID=40&md5=c6de8d8dbbbd9f29f53a8b63784ee91a
145.
Levy RJ, Golomb G, Wolfrum J, Lund SA, Schoen FJ, Langer R. Local controlled-release of diphosphonates from ethylenevinylacetate matrices prevents bioprosthetic heart valve calcification. Transactions - American Society for Artificial Internal Organs [Internet]. 1985;31:459–63. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022177375&partnerID=40&md5=cbde27adfb3d0cec9e86f5b60542f39f
146.
Friedman M, Brayer L, Golomb G, Hiller H. Prevention of plaque accumulation by local application of a sustained release delivery system of chlorhexidine. Journal of Controlled Release [Internet]. 1984;1(2):157–60. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021673293&doi=10.1016%2f0168-3659%2884%2990009-9&partnerID=40&md5=e5276d26e48f7a7c194dcf81df4e7df3
147.
HIRSCHFELD Z, FRIEDMAN M, GOLOMB G, BEN‐YAACOV D. New sustained release dosage form of chlorhexidine for dental use: use for plaque control in partial denture wearers. Journal of Oral Rehabilitation [Internet]. 1984;11(5):477–82. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021200290&doi=10.1111%252fj.1365-2842.1984.tb00600.x&partnerID=40&md5=ec51014663c33548f11184fe9ee79587
148.
Golomb G, Friedman M, Soskolne A, Stabholz A, Sela MN. Sustained Release Device Containing Metronidazole for Periodontal Use. Journal of Dental Research [Internet]. 1984;63(9):1149–53. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021144771&doi=10.1177%252f00220345840630091101&partnerID=40&md5=0d13344341a3f91c39bfa210829d6274
149.
Soskolne A, Golomb G, Friedman M, Sela MN. New sustained release dosage form of chlorhexidine for dental use: II. Use in periodontal therapy. Journal of Periodontal Research [Internet]. 1983;18(3):330–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0020602007&doi=10.1111%252fj.1600-0765.1983.tb00368.x&partnerID=40&md5=e62d831fd088154b6da8b969b92ec9c5
150.
Friedman M, Golomb G. New sustained release dosage form of chlorhexidine for dental use: I. Development and kinetics of release. Journal of Periodontal Research [Internet]. 1982;17(3):323–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0020408104&doi=10.1111%252fj.1600-0765.1982.tb01160.x&partnerID=40&md5=1adc8d264173a9ddb19a8f6f93b8b34e
151.
Soskolne WA, Friedman M, Golomb G, Sela M. Sustained release reservoirs of chlorhexidine in periodontal pockets. Journal of Dental Research [Internet]. 1982;61(Abs.):No. 856. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0020047917&partnerID=40&md5=c9d222791310cd4c889ae19a39915dd0
152.
Friedman M, Golomb G. Dissolution rate of fluorides: Quality test of dentifrices. Journal of Dental Research [Internet]. 1980;59(SPEC.1SS. DI):1879. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019296129&partnerID=40&md5=70a09ca673d7937be56c86817670788c
153.
Friedman M, Golomb G, Brayer L, Ch. H. Sustained release chlorhexidine preparations for topical use. Journal of Dental Research [Internet]. 1980;59(SPEC. ISSUE B):No. 72. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019194934&partnerID=40&md5=da44a1bad30204908d472de21a96c4cf